Sensitization Study of ATx201 in Healthy Volunteers
Status:
Completed
Trial end date:
2018-03-15
Target enrollment:
Participant gender:
Summary
This is a Phase I, single-site study to evaluate the sensitization potential of topically
applied ATx201 GEL, 2% and 4%, along with a placebo control, in healthy human subjects.